ATP6V1F is a novel prognostic biomarker and potential immunotherapy target for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the deadliest malignancies worldwide, with late detection, ineffective treatment and poor overall survival. Immunotherapy, including immune checkpoint inhibitor (ICI) t...

Source: BMC Medical Genomics - August 16, 2023 Category: Genetics & Stem Cells Authors: Xinyao Hu, Dan Li, Hua Zhu, Tao Yu, Xiaoxing Xiong and Ximing Xu Tags: Research Source Type: research